Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine, Oxaliplatin, and Bevacizumab in Advanced/Metastatic Colorectal Cancer
NCT00345761Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Feb 2006
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Feb 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00345761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345761.